President Trump reverses Biden's order to cap out-of-pocket costs for prescription drugs, potentially increasing costs for Medicare and Medicaid recipients.
Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.